Improving Immunotherapy Through Glycodesign

• Matthew J. Buettner,
• Sagar R. Shah,
• Christopher T. Saeui,
• Christopher T. Saeui,
• Ryan Ariss,
• Kevin J. Yarema

Affiliations

Matthew J. Buettner

Department of Biomedical Engineering and the Translational Tissue Engineering Center, The Johns Hopkins University, Baltimore, MD, United States

Sagar R. Shah

Department of Biomedical Engineering and the Translational Tissue Engineering Center, The Johns Hopkins University, Baltimore, MD, United States

Christopher T. Saeui

Department of Biomedical Engineering and the Translational Tissue Engineering Center, The Johns Hopkins University, Baltimore, MD, United States

Christopher T. Saeui

Pharmacology/Toxicology Branch I, Division of Clinical Evaluation and Pharmacology/Toxicology, Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, MD, United States

Ryan Ariss

Department of Biomedical Engineering and the Translational Tissue Engineering Center, The Johns Hopkins University, Baltimore, MD, United States

Kevin J. Yarema

Department of Biomedical Engineering and the Translational Tissue Engineering Center, The Johns Hopkins University, Baltimore, MD, United States